Guangzhou Baiyunshan Pharmaceutical Holdings
600332.SS
#3104
Rank
NZ$9.06 B
Marketcap
NZ$5.58
Share price
0.00%
Change (1 day)
-9.47%
Change (1 year)

Earnings for Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SS)

Earnings in 2026 (TTM): NZ$1.17 Billion

According to Guangzhou Baiyunshan Pharmaceutical Holdings's latest financial reports the company's current earnings are NZ$11.47 Billion. In 2024 the company made an earning of NZ$0.87 Billion a decrease over its 2023 earnings that were of NZ$1.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guangzhou Baiyunshan Pharmaceutical Holdings from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$1.17 B
2024 NZ$0.87 B-30.8%
2023 NZ$1.25 B-4.38%
2022 NZ$1.31 B4.32%
2021 NZ$1.26 B35.17%
2020 NZ$0.93 B-10.54%
2019 NZ$1.04 B-1.38%
2018 NZ$1.05 B64.22%
2017 NZ$0.64 B27.61%
2016 NZ$0.50 B12.59%
2015 NZ$0.44 B9.34%
2014 NZ$0.41 B6.26%
2013 NZ$0.38 B162.26%
2012 NZ$0.14 B63.15%
2011 NZ$90.27 M9.1%
2010 NZ$82.74 M40.76%
2009 NZ$58.78 M9.3%
2008 NZ$53.78 M-50.94%
2007 NZ$0.10 B32.74%
2006 NZ$82.57 M26.99%
2005 NZ$65.02 M84.93%
2004 NZ$35.16 M-41.1%
2003 NZ$59.7 M-0.86%
2002 NZ$60.22 M